tradmap

ZVRA Earnings Zevra Therapeutics, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$3 -$1 $1 $0 2016 2016 2016 2017 2017 2017 2020 2021 2024 2025
EPS
Revenue (annual)
$0 $53M $106M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$106M -$11M $83M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $1 $0 Q2 '20 Q1 '21 Q3 '21 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $20M $40M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$36M $19M $75M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–33 of 33
Q2 20262026-06-300.742026-08-0510-Q
Q1 20262026-03-310.602026-05-0610-Q
FY 20252025-12-311.352026-03-0910-K
Q3 20252025-09-301.162025-11-0510-Q
Q2 20262025-06-301.162026-08-0510-Q
Q1 20262025-03-31-0.062026-05-0610-Q
FY 20252024-12-31-2.282026-03-0910-K
Q3 20252024-09-30-1.592025-11-0510-Q
Q2 20252024-06-30-0.872025-08-1210-Q
FY 20212021-12-31-2.112022-03-3110-K
Q3 20212021-09-30-2.162021-11-1010-Q
Q2 20212021-06-30-2.422021-08-1310-Q
Q1 20212021-03-31-2.492021-05-1410-Q
FY 20212020-12-31-3.212022-03-3110-K
Q3 20212020-09-30-2.082021-11-1010-Q
Q2 20212020-06-30-1.432021-08-1310-Q
Q1 20212020-03-31-1.922021-05-1410-Q
Q3 20202019-09-30-0.652020-10-3010-Q
Q2 20202019-06-30-0.782020-08-1210-Q
Q3 20192018-09-30-3.332019-11-1410-Q
Q2 20192018-06-30-2.412019-08-1310-Q
FY 20172017-12-31-0.722018-03-3010-K
FY 20172017-09-30-0.682018-03-3010-K
Q2 20182017-06-30-1.562018-08-1010-Q
FY 20172017-03-31-1.112018-03-3010-K
FY 20172016-12-31-0.682018-03-3010-K
FY 20172016-09-30-0.922018-03-3010-K
FY 20172016-06-30-0.582018-03-3010-K
FY 20172016-03-31-0.202018-03-3010-K
FY 20162015-12-31-0.642017-03-1010-K
FY 20162015-09-30-0.682017-03-1010-K
FY 20162015-06-30-2.452017-03-1010-K
FY 20162015-03-31-2.502017-03-1010-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.